Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating toripalimab in combination with platinum-based induction chemotherapy regimens for locally advanced nasoph…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC [Phase 3]
Phase 3 clinical trial evaluating the combination of Becotatug Vedotin and Sintilimab for locoregionally advanced nasopharyngeal carcinoma i…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors [Phase 2]
A Phase 2 trial investigates the combination of atezolizumab and bevacizumab in several rare solid tumors, with the study currently not recr…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Proton Therapy for Recurrent Nasopharyngeal Carcinoma [NA]
This clinical trial update describes a study evaluating proton therapy for recurrent nasopharyngeal carcinoma, which is currently recruiting…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response [Phase 3]
A Phase 3 trial is evaluating a reduced-dose radiotherapy approach for stage III nasopharyngeal carcinoma, and recruitment is ongoing.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma [Phase 2]
This clinical trial update states a Phase 2 study of Becotatug Vedotin as adjuvant therapy for high-risk Nasopharyngeal Carcinoma, currently…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial compares Sapylin (OK-432) inhalation to dexamethasone inhalation for CCRT-induced oral mucositis in nasopharyngeal carcinoma…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Nasopharyngeal Carcinoma Post IMRT
A ClinicalTrials.gov entry notes an active but not recruiting trial investigating Nasopharyngeal Carcinoma after IMRT, sponsored by Universi…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) [Phase 1, Phase 2]
Genmab's PRO1160 (GEN1160) Phase 1/2 trial in relapsed or refractory non-Hodgkin lymphoma has been terminated; the study also included renal…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Combining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC Patients [NA]
A completed study evaluating MRI combined with contrast-enhanced ultrasound to detect small cervical lymph node metastases in patients with …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC. [Phase 2]
Phase 2 clinical trial evaluating Envafolimab with chemoradiotherapy and recombinant human endostatin for locally advanced nasopharyngeal ca…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial [Phase 2]
A Phase II clinical trial evaluating MRG003 in combination with immunotherapy for recurrent/metastatic nasopharyngeal carcinoma, currently n…
-
CLINICAL_TRIALS other · 2026-02-10Clinical Trial Update: Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC) [Phase 2]
A Phase 2 trial is investigating induction therapy with gemcitabine, docetaxel, and toripalimab for EBV-associated nasopharyngeal carcinoma.…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy
Clinical trial update on CROSSROAD comparing re-induction chemotherapy versus direct radiotherapy for locally advanced nasopharyngeal carcin…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update for MRG003 in recurrent or metastatic nasopharyngeal carcinoma. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients [Phase 3]
Phase 3 trial comparing concurrent chemoradiotherapy with and without adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma; t…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of Scipibaimab and tislelizumab for first-line treatment-failed recurrent/metastatic nas…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Timing Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
This entry updates a Phase 2 clinical trial investigating the optimal timing of immunotherapy administered during neoadjuvant chemotherapy f…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC [Phase 2]
Phase 2 trial evaluating a PD-1 inhibitor plus chemotherapy followed by immediate versus selective re-irradiation for locally advanced recur…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma [Phase 3]
The document reports a Phase 3 clinical trial evaluating Anlotinib in combination with immunotherapy and chemoradiotherapy for high-risk nas…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC [Phase 1]
Phase 1 study evaluating TGF-beta resistant cytotoxic T-lymphocytes for Epstein-Barr virus–positive nasopharyngeal carcinoma. The trial is c…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
This clinical trial update notes an ongoing study evaluating intensity-modulated radiotherapy (IMRT) alone for stage I nasopharyngeal carcin…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating short-course tislelizumab in combination with chemoradiotherapy for nasopharyngeal carcinoma; the study is not yet …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical trial testing consolidation nivolumab after concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal…